The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Maintenance therapy with the TLR-9 agonist MGN1703 in the phase II IMPACT study of metastatic colorectal cancer patients: A subgroup with improved overall survival.
 
Hans-Joachim Schmoll
No Relationships to Disclose
 
Jorge Riera-Knorrenschild
No Relationships to Disclose
 
Hans-Georg Kopp
No Relationships to Disclose
 
Frank Mayer
No Relationships to Disclose
 
Hendrik Kroening
No Relationships to Disclose
 
Dieter Nitsche
No Relationships to Disclose
 
Jan Kuhlmann
No Relationships to Disclose
 
Reinhard Ziebermayr
No Relationships to Disclose
 
Johannes Andel
No Relationships to Disclose
 
Dirk Arnold
No Relationships to Disclose
 
Manuel Schmidt
Employment - MOLOGEN
 
Burghardt Wittig
Stock and Other Ownership Interests - MOLOGEN
Research Funding - MOLOGEN (Inst)
Patents, Royalties, Other Intellectual Property - MOLOGEN
 
Werner Scheithauer
No Relationships to Disclose